Related Experiment Video
Updated: May 10, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Gastrodin attenuates hypercholesterolaemia through regulating the PCSK9/LDLR signalling pathway by suppressing HNF-1α
Yaowen Zhang1, Lan Han2, Qiyuan Ning1
1School of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, 230011, China.
Insights
Gastrodin (Gas) effectively treats hypercholesterolaemia by regulating cholesterol metabolism. It inhibits PCSK9 expression and increases LDLR transcription, offering new therapeutic insights for hyperlipidaemia.
Area of Science:
- Pharmacology
- Biochemistry
- Cardiovascular Research
Background:
- Hypercholesterolaemia is a major risk factor for cardiovascular diseases (CVDs).
- Gastrodin (Gas), from Gastrodia elata Bl., possesses lipid-lowering properties, but its mechanism in CVD treatment is unclear.
- The PCSK9/LDLR pathway is crucial for cholesterol metabolism regulation.
Purpose of the Study:
- To investigate the inhibitory effect of Gastrodin on hypercholesterolaemia.
- To determine if Gastrodin's hypolipidemic effects are linked to the PCSK9/LDLR signalling pathway.
Main Methods:
- Hypercholesterolaemia induced in mice via high-fat diet (HFD) for 12 weeks.
- In vivo analysis of therapeutic effects and pathways.
- In vitro verification using western blotting, qRT-PCR, molecular docking, and transfection.
Main Results:
- Gastrodin demonstrated significant therapeutic effects against hypercholesterolaemia in HFD mice.
- Gastrodin attenuated HFD-induced hepatic lipid accumulation and liver damage.
- Mechanistically, Gas inhibited JAK2/STAT3 signalling, suppressing HNF-1α and promoting FoxO3a to decrease PCSK9 expression, while activating SREBP2 to increase LDLR transcription.
Conclusions:
- Gastrodin effectively treats hyperlipidaemia by modulating the PCSK9/LDLR pathway.
- These findings offer novel insights into hyperlipidaemia prevention and treatment strategies.
Background:
Hypercholesterolaemia is a prevalent etiological factor of cardiovascular diseases (CVDs). Gastrodin (Gas), the paramount active constituent in Gastrodia elata Bl., has lipid-lowering and anti-inflammatory properties for the treatment of CVDs. Nevertheless, the underlying mechanism responsible for hypolipidemic efficacy remains to be elucidated. The signalling pathwayof PCSK9/LDLR is a key signalling pathway that regulates cholesterol metabolism.
Purpose:
This investigation elucidated whether Gas has an inhibitory effect on hypercholesterolaemia and whether this effect is associated with the regulation of the PCSK9/LDLR signalling pathway.
Methods:
We induced hypercholesterolaemia of mice by feeding them a high-fat diet (HFD) for 12 weeks to analyse the therapeutic effects and related pathways of Gas in vivo. In vitro, western blotting, qRT-PCR, molecular docking, and transfection were employed to verify the molecular mechanism of action of Gas in the treatment of hypercholesterolaemia.
Results:
Gas exhibited potent therapeutic effects against hypercholesterolaemia in HFD mice. Moreover, the HFD-induced hepatic lipid accumulation and liver damage were attenuated by Gas. Mechanistically, Gas decreased the expression of PCSK9 via inhibiting the JAK2/STAT3 signalling pathway to suppress HNF-1α and promote FoxO3a. In addition, Gas increased LDLR transcription via SREBP2 activation.
Conclusion:
Collectively, our data provide new insights into the prevention and treatment of hyperlipidaemia by Gas.
More Related Videos
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
GPCRs Regulate Adenylyl Cylase Activity
Hormonal Regulation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
GPCR Desensitization
Lipid Digestion

